Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.710
-0.010 (-0.58%)
At close: Feb 27, 2026, 4:00 PM EST
1.670
-0.040 (-2.34%)
After-hours: Feb 27, 2026, 7:59 PM EST
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $173.71 million as of February 27, 2026. Its market cap has increased by 15.53% in one year.
Market Cap
173.71M
Enterprise Value
148.33M
1-Year Change
15.53%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $173.71M, a decrease of -52.21%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 173.71M | -15.35% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 184.62M |
| Molecular Partners AG | 183.61M |
| Vaxart | 180.22M |
| Fate Therapeutics | 179.95M |
| Jyong Biotech | 176.87M |
| Acumen Pharmaceuticals | 172.03M |
| Karyopharm Therapeutics | 171.52M |
| Rani Therapeutics Holdings | 167.70M |